1.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: FHCRC-760.1, NCI-V94-0403
|
|
2.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: RPMI-DS-9422, NCI-T93-0177D, T93-0177
|
|
3.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RPMI-DS-9429, NCI-T94-0072D, T94-0072
|
|
4.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: NCI
Protocol IDs: MDA-DM-94028, NCI-T95-0064D, T95-0064
|
|
5.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: NCI
Protocol IDs: NCI-92-C-0161I, NCI-MB-294, NCI-T92-0018N, T92-0018
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: IDB-IL-6/RENAL, NCI-T93-0038N, T93-0038
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: IDB-IL-6/MELANOMA, NCI-T93-0049N, T93-0049
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CCF-RPC-3272F, NCI-B93-0005, B93-0005
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 17 and over
Sponsor: NCI
Protocol IDs: MDA-DM-93081, NCI-T93-0130C, T93-0130
|
|
10.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: DFCI-93079, NCI-T93-0001D, T93-0001
|
|
11.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-94-C-0023C, NCI-MB-320, NCI-T93-0042N, T93-0042
|
|
12.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CCF-RPC-2520E, NCI-T93-0158C, T93-0158
|
|
13.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: over 60
Sponsor:
Protocol IDs: MSKCC-93134, NCI-V94-0360
|
|
14.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: DMS-9224, NCI-T93-0026D, T93-0026
|
|
15.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 1 to 21
Sponsor: NCI
Protocol IDs: CCG-0931
|
|
16.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-9343
|
|
17.
|
Phase: Phase I
Type: Supportive care, Treatment
Status: Closed
Age: 18 to 60
Sponsor: NCI
Protocol IDs: MDA-DM-93012, NCI-T93-0160D, T93-0160
|
|
18.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-96-C-0007K, NCI-MB-361, NCI-T95-0096N, T95-0096
|
|
19.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-91-C-199B, NCI-T91-0150N, T91-0150
|
|
20.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 16-75
Sponsor:
Protocol IDs: WPCI-9175, NCI-V91-0215
|
|
21.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CCF-RPC-3272E, NCI-B91-0019, B91-0019
|
|
22.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-92-C-0143, NCI-T92-0040N, T92-0040
|
|
23.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: NCI
Protocol IDs: IDB-IL-6, NCI-T92-0049O, T92-0049
|
|
24.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: IDB-IL-6/120HR, NCI-T92-0062O, T92-0062
|
|
25.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: GOG-9202
|
